Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


Early Childhood Vision Screening in Hawai'i Utilizing a Hand-Held Screener.

Chang DA, Ede RC, Chow DC, Souza RD, Gangcuangco LM, Hanks N, Nakamoto BK, Mitchell B, Masutani AT, Fisk S, Shikuma CM, Dill JE.

Hawaii J Med Public Health. 2015 Sep;74(9):292-6.


Assessing Pistia stratiotes for phytoremediation of silver nanoparticles and Ag(I) contaminated waters.

Hanks NA, Caruso JA, Zhang P.

J Environ Manage. 2015 Dec 1;164:41-5. doi: 10.1016/j.jenvman.2015.08.026. Epub 2015 Sep 3.


Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.

Longenecker CT, Kitch D, Sax PE, Daar ES, Tierney C, Gupta SK, McComsey GA; AIDS Clinical Trials Group Study A5224s Team.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):168-77. doi: 10.1097/QAI.0000000000000557.


Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).

Ndhlovu LC, Umaki T, Chew GM, Chow DC, Agsalda M, Kallianpur KJ, Paul R, Zhang G, Ho E, Hanks N, Nakamoto B, Shiramizu BT, Shikuma CM.

J Neurovirol. 2014 Dec;20(6):571-82. doi: 10.1007/s13365-014-0279-x. Epub 2014 Sep 17.


Expansion of U.S. emergency medical service routing for stroke care: 2000-2010.

Hanks N, Wen G, He S, Song S, Saver JL, Cen S, Kim-Tenser M, Mack W, Sanossian N.

West J Emerg Med. 2014 Jul;15(4):499-503. doi: 10.5811/westjem.2014.2.20388.


Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase.

Brehm JH, Lalama CM, Hughes MD, Haubrich R, Riddler SA, Sluis-Cremer N, Mellors JW; AIDS Clinical Trials Group Study A5142 Protocol Team.

J Acquir Immune Defic Syndr. 2011 Apr;56(4):344-8. doi: 10.1097/QAI.0b013e31820cf029.


A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.

Hammer SM, Ribaudo H, Bassett R, Mellors JW, Demeter LM, Coombs RW, Currier J, Morse GD, Gerber JG, Martinez AI, Spreen W, Fischl MA, Squires KE; AIDS Clinical Trials Group (ACTG) 372A Study Team.

HIV Clin Trials. 2010 Nov-Dec;11(6):312-24. doi: 10.1310/hct1106-312.


Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.

Lok JJ, Bosch RJ, Benson CA, Collier AC, Robbins GK, Shafer RW, Hughes MD; ALLRT team.

AIDS. 2010 Jul 31;24(12):1867-76. doi: 10.1097/QAD.0b013e32833adbcf.


Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.

Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, Ellis RJ, Rodriguez B, Coombs RW, Schifitto G, McArthur JC, Robertson K; AIDS Clinical Trials Group 736 Study Team.

AIDS. 2009 Jul 17;23(11):1359-66. doi: 10.1097/QAD.0b013e32832c4152.


Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.

Haubrich RH, Riddler SA, DiRienzo AG, Komarow L, Powderly WG, Klingman K, Garren KW, Butcher DL, Rooney JF, Haas DW, Mellors JW, Havlir DV; AIDS Clinical Trials Group (ACTG) A5142 Study Team.

AIDS. 2009 Jun 1;23(9):1109-18. doi: 10.1097/QAD.0b013e32832b4377.


Class-sparing regimens for initial treatment of HIV-1 infection.

Riddler SA, Haubrich R, DiRienzo AG, Peeples L, Powderly WG, Klingman KL, Garren KW, George T, Rooney JF, Brizz B, Lalloo UG, Murphy RL, Swindells S, Havlir D, Mellors JW; AIDS Clinical Trials Group Study A5142 Team.

N Engl J Med. 2008 May 15;358(20):2095-106. doi: 10.1056/NEJMoa074609.


Explaining the adoption of telemedicine services: an analysis of a paediatric telemedicine service.

Cook DJ, Doolittle GC, Ferguson D, Hanks N, Hood J, Howard M, Troha J, Mehling D, Zurbuchen N.

J Telemed Telecare. 2002;8 Suppl 2:106-7.


PPD skin reactivity and anergy in HIV-infected patients in Hawaii.

Shikuma CM, Congdon S, Hanks N, Souza S, Kindrick A, Case S, Heath-Chiozzi M.

Hawaii Med J. 1996 Jun;55(6):100-3.


Making Faces across the Gulf..

Hanks N.

Science. 1971 Aug 6;173(3996):479. No abstract available.


Protein-losing enteropathy caused by a retained intestinal tube.

Gruhl VR, Weis HJ, Bailey JJ, Hanks NN.

Gastroenterology. 1970 Feb;58(2):217-22. No abstract available.


Aerospace pilot training and selection.

Hanks NJ.

Ann N Y Acad Sci. 1965 Nov 22;134(1):376-84. No abstract available.


Supplemental Content

Loading ...
Support Center